Search | Clinical Trials Finder

Conditions: Decision Making, Bipolar Disorder
Interventions: Decision Making Tutorial; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: Not listed
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Acute Leukemia, Myelodysplastic Syndrome(MDS), Myeloproliferative Neoplasm (MPN)
Interventions: Thiotepa, Fludarabine, Busulfan, PBSC infusion; Drug · Procedure
Lead sponsor: Sawa Ito, MD; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Chronic Pain
Interventions: painTRAINER®, Skills-Based VR; Behavioral · Device
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 13 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Non-small Cell Lung Cancer
Interventions: Blueberry powder; Dietary Supplement
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Occupational Stress, Health Behavior, Safety Issues, Mental Health Wellness 1
Interventions: Total Worker Health Mindfulness Enhanced Program; Behavioral
Lead sponsor: Kerry Kuehl; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Salem, Oregon • Wilsonville, Oregon

Conditions: Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant, Recurrent Malignant Brain Neoplasm, Resectable Brain Neoplasm
Interventions: Ad-hCMV-Flt3L, Ad-hCMV-TK, Biospecimen Collection, Magnetic Resonance Imaging, Survey Administration, Tumor Resection, Valacyclovir; Genetic · Procedure · Other + 1 more
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 3 Years to 39 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Overweight and Obesity, Weight Loss
Interventions: 250 kcal Dietary Energy Restriction, Aerobic Exercise; Other
Lead sponsor: North Dakota State University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Dementia, Chronic Pain
Interventions: PICT Workbook, Information Pamphlet; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 21 Years to 100 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Low Back Pain
Interventions: Exercise and Meditation, Control; Behavioral
Lead sponsor: Duquesne University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Prostate Cancer
Interventions: Focal brachytherapy with PSMA PET imaging, (18F)DCFPyL; Radiation · Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
Interventions: CliniMACS® CD34 Reagent System, Fludarabine, Melphalan, Rabbit ATG, Double Umbilical Cord Blood Transplantation, Haplo-Identical Cord Transplantation; Device · Drug · Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Childhood, Energy Density, Diet Quality
Interventions: family-based obesity prevention lifestyle intervention; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 2 Years to 5 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Asthma in Children
Interventions: Combined coping skills + asthma management, Standard Asthma Management (AM); Behavioral
Lead sponsor: Erin M Rodriguez; Other
Eligibility: 8 Years and older
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Austin, Texas

Conditions: PTSD, Suicidal Ideation, Suicide, Attempted, Trauma, Psychological
Interventions: Prolonged exposure; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Pre Diabetes, Overweight and Obesity
Interventions: Time restricted eating; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 50 Years to 70 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Stage III Liver Cancer, Stage IV Liver Cancer
Interventions: Atezolizumab, Bevacizumab, Biospecimen Collection, Cisplatin, Computed Tomography, Conventional Magnetic Resonance Imaging, Gemcitabine Hydrochloride; Biological · Procedure · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 37
States / cities: Auburn, California • Berkeley, California • Fremont, California + 27 more

Conditions: Pain, Postoperative
Interventions: Combined Bupivacaine and Exparel, Normal Saline (NS); Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Crohn Disease, Ulcerative Colitis (UC)
Interventions: Psychologist-administered Cognitive Behavioral Therapy, Self-Administered Cognitive Behavioral Therapy; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Coronary Artery Disease
Interventions: Hybrid Coronary Revascularization (HCR), Coronary Artery Bypass Grafting (CABG); Procedure
Lead sponsor: Emory University; Other
Eligibility: Not listed
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Anesthesia, Local, Photodamaged Skin, Topical and Infiltration Anesthetic Toxicity
Interventions: 2.5 g of lidocaine 23% / tetracaine 7% ointment without occlusion, 7.5 g lidocaine 2.5%/ prilocaine 2.5% cream with occlusion; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Lymphomas, Solid Tumors, NSCLC, Metastatic Colon Carcinoma, Granulosa Cell Ovarian Cancer
Interventions: TRC102, CT scan, Lomotil, Prochlorperazine, Metoclopramide, 5-HT3 antagonist, Aprepitant, Biopsy; Drug · Diagnostic Test · Other + 1 more
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Colitis, Ulcerative
Interventions: Combined Anti-inflammatory Diet (CAID); Behavioral
Lead sponsor: Transparency Life Sciences; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2015
U.S. locations: 1
States / cities: Brookline, Massachusetts

Conditions: Iliac Artery Stenosis
Interventions: Epic™ Nitinol Stent System, Anti-platelet therapy, Anti-coagulation therapy; Device · Drug
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 28
States / cities: Tucson, Arizona • Brandon, Florida • Fort Lauderdale, Florida + 24 more

Conditions: Difficult Endotracheal Intubation
Interventions: aScope (Ambu Inc. 6740 Baymeadow Drive Glen Burnie, MD), Control; Device
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Louisville, Kentucky

Search by objective public record fields.

Cognitive De-Biasing and the Assessment of Pediatric Bipolar Disorder

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain

Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer

Corrections Work's Adverse Effects and a Total Worker Health Program to Enhance Well-being

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

microRNA Testing for Identification of Personalized Weight Management

Developing a Pain Identification and Communication Toolkit

Meditation and Exercise to Treat Chronic Back Pain

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

Eat Healthy for Families

A Coping Skills Program for Children With Asthma

Enhancing the Effectiveness of Prolonged Exposure Among Suicidal Individuals With PTSD

TRE With Physical Activity for Weight Management

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

Long-acting Local Vaginal Cuff Anesthesia Following Hysterectomy

Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)

HCR vs. CABG Study

Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face

TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas

Decentralized Dietary UC Pilot Trial

EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries

Video-laryngoscope With a Novel Video-stylet for Difficult Intubation